Bath & Body Works Class Action Reminder
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1h ago
0mins
Should l Buy BBWI?
Source: Globenewswire
- Class Action Notice: Rosen Law Firm reminds investors who purchased Bath & Body Works (NYSE: BBWI) securities between June 4, 2024, and November 19, 2025, that they must apply to be lead plaintiff by March 16, 2026, to participate in the class action and potentially receive compensation.
- Lawsuit Background: The lawsuit alleges that Bath & Body Works made materially false statements during the Class Period, failing to disclose that its strategy of 'adjacencies, collaborations, and promotions' was not effectively growing its customer base, resulting in investor losses.
- Law Firm's Credentials: Rosen Law Firm specializes in securities class actions and recovered over $438 million for investors in 2019 alone, being ranked first by ISS Securities Class Action Services in 2017, highlighting its successful track record in this field.
- Investor Guidance: Investors are advised to carefully select counsel and avoid working with inexperienced middlemen to ensure effective legal representation and support in the class action.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy BBWI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on BBWI
Wall Street analysts forecast BBWI stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for BBWI is 20.14 USD with a low forecast of 15.00 USD and a high forecast of 26.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
14 Analyst Rating
4 Buy
10 Hold
0 Sell
Moderate Buy
Current: 23.050
Low
15.00
Averages
20.14
High
26.00
Current: 23.050
Low
15.00
Averages
20.14
High
26.00
About BBWI
Bath & Body Works, Inc. is a global omnichannel retailer focused on personal care and home fragrance. The Company offers a range of fragrances for the body and home, including selling collections for 3-wick candles, home fragrance diffusers, fine fragrance mists, liquid hand soaps, body lotions and body creams. It delivers customers their fragrances in multiple forms and categories. The Company sells merchandise through its retail stores in the United States and Canada, and through its Websites and other channels, under the Bath & Body Works, White Barn and other brand names. The Company’s international business is conducted through franchise, license and wholesale partners. It provides in-store experiences at more than 1,890 Company-operated Bath & Body Works locations in the United States and Canada, more than 525 international franchised locations and an online storefront at bathandbodyworks.com. Additionally, it offers a buy online pick-up in-store (BOPIS) option.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Class Action Notice for Bath & Body Works Investors
- Class Action Deadline: Investors who purchased Bath & Body Works (NYSE:BBWI) securities between June 4, 2024, and November 19, 2025, should note that the deadline to apply as lead plaintiff is March 16, 2026, potentially entitling them to compensation.
- Fee Structure: Participants in the class action are not required to pay any upfront fees, as the law firm operates on a contingency fee basis, which alleviates financial burdens for investors and encourages broader participation.
- Lawsuit Allegations: The lawsuit claims that Bath & Body Works made materially false statements during the class period, failing to disclose that its strategy of
See More
Bath & Body Works Class Action Reminder
- Class Action Notice: Rosen Law Firm reminds investors who purchased Bath & Body Works (NYSE: BBWI) securities between June 4, 2024, and November 19, 2025, that they must apply to be lead plaintiff by March 16, 2026, to participate in the class action and potentially receive compensation.
- Lawsuit Background: The lawsuit alleges that Bath & Body Works made materially false statements during the Class Period, failing to disclose that its strategy of 'adjacencies, collaborations, and promotions' was not effectively growing its customer base, resulting in investor losses.
- Law Firm's Credentials: Rosen Law Firm specializes in securities class actions and recovered over $438 million for investors in 2019 alone, being ranked first by ISS Securities Class Action Services in 2017, highlighting its successful track record in this field.
- Investor Guidance: Investors are advised to carefully select counsel and avoid working with inexperienced middlemen to ensure effective legal representation and support in the class action.
See More
Bath & Body Works Faces Class Action Lawsuit
- Earnings Miss: Bath & Body Works reported Q2 2025 earnings of $0.30 per share, a 55.8% year-over-year decline, missing prior guidance by $0.03, which led to a 6.9% drop in stock price to $29.36, indicating a significant deterioration in profitability.
- Performance Decline: In Q3 2025, the company experienced a 1% year-over-year revenue decline, failing to meet its growth guidance of 1-3%, with net income falling 26% to $77 million, highlighting weaknesses in market competitiveness.
- Strategic Shift: The company acknowledged that its strategy of “adjacencies, collaborations, and promotions” failed to effectively grow its customer base, deciding to exit certain adjacencies and refocus on core categories to improve performance and restore growth.
- Legal Action: The class action lawsuit alleges that the company failed to disclose significant adverse facts about its business and prospects during the class period, misleading investors and potentially exposing them to greater legal and financial risks.
See More
Class Action Lawsuit Filed Against Bath & Body Works, Inc.
- Lawsuit Background: Bath & Body Works, Inc. (NYSE: BBWI) is facing a class action lawsuit for alleged violations of federal securities laws, targeting the company and its officers on behalf of investors who purchased securities between June 4, 2024, and November 19, 2025.
- Allegations Details: The complaint alleges that throughout the class period, defendants made materially false and misleading statements while failing to disclose adverse facts about the company's business and prospects, misleading investors regarding its financial health.
- Financial Guidance Missteps: The lawsuit claims that the company's strategy of pursuing
See More
Class Action Notice for Bath & Body Works Securities
- Class Action Notice: Rosen Law Firm reminds investors who purchased Bath & Body Works securities between June 4, 2024, and November 19, 2025, that they must apply to be lead plaintiff by March 16, 2026, to participate in the class action and potentially receive compensation.
- Lawsuit Background: The lawsuit alleges that Bath & Body Works made materially false statements during the Class Period, failing to disclose that its strategy of 'adjacencies, collaborations, and promotions' was not effectively growing its customer base, resulting in investor losses.
- Law Firm Advantages: Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, demonstrating its successful track record and resource advantages, urging investors to select experienced legal counsel wisely.
- Investor Action Recommendations: Investors can visit Rosen Law Firm's website or call the toll-free number for more information on how to participate in the lawsuit, ensuring they have appropriate legal representation in the class action.
See More
Multiple Companies Face Class Action Lawsuits
- Varonis Systems Lawsuit: During the class period from February 4, 2025, to October 28, 2025, Varonis is accused of failing to sustain its annual recurring revenue growth, which has severely undermined investor confidence in the company's prospects, with a lead plaintiff deadline set for March 9, 2026.
- Ardent Health Allegations: Ardent Health faces accusations from July 18, 2024, to November 12, 2025, of inaccurately assessing the collectability of accounts receivable, leading to significant misrepresentation of its financial health, with investors required to act by March 9, 2026.
- CoreWeave Risk Disclosure: CoreWeave is alleged to have overstated its ability to meet customer demand during the period from March 28, 2025, to December 15, 2025, failing to adequately disclose the risks associated with reliance on a single third-party data center, which could materially impact revenue, with a lead plaintiff deadline of March 13, 2026.
- Bath & Body Works Financial Misrepresentation: Bath & Body Works is accused of failing to meet its financial guidance during the period from June 4, 2024, to November 19, 2025, with its brand collaboration strategy not effectively growing its customer base, requiring investor action by March 16, 2026.
See More
Class Action Notice for Bath & Body Works Investors
- Class Action Deadline: Investors who purchased Bath & Body Works (NYSE:BBWI) securities between June 4, 2024, and November 19, 2025, should note that the deadline to apply as lead plaintiff is March 16, 2026, potentially entitling them to compensation.
- Fee Structure: Participants in the class action are not required to pay any upfront fees, as the law firm operates on a contingency fee basis, which alleviates financial burdens for investors and encourages broader participation.
- Lawsuit Allegations: The lawsuit claims that Bath & Body Works made materially false statements during the class period, failing to disclose that its strategy of
See More
Bath & Body Works Class Action Reminder
- Class Action Notice: Rosen Law Firm reminds investors who purchased Bath & Body Works (NYSE: BBWI) securities between June 4, 2024, and November 19, 2025, that they must apply to be lead plaintiff by March 16, 2026, to participate in the class action and potentially receive compensation.
- Lawsuit Background: The lawsuit alleges that Bath & Body Works made materially false statements during the Class Period, failing to disclose that its strategy of 'adjacencies, collaborations, and promotions' was not effectively growing its customer base, resulting in investor losses.
- Law Firm's Credentials: Rosen Law Firm specializes in securities class actions and recovered over $438 million for investors in 2019 alone, being ranked first by ISS Securities Class Action Services in 2017, highlighting its successful track record in this field.
- Investor Guidance: Investors are advised to carefully select counsel and avoid working with inexperienced middlemen to ensure effective legal representation and support in the class action.
See More
Bath & Body Works Faces Class Action Lawsuit
- Earnings Miss: Bath & Body Works reported Q2 2025 earnings of $0.30 per share, a 55.8% year-over-year decline, missing prior guidance by $0.03, which led to a 6.9% drop in stock price to $29.36, indicating a significant deterioration in profitability.
- Performance Decline: In Q3 2025, the company experienced a 1% year-over-year revenue decline, failing to meet its growth guidance of 1-3%, with net income falling 26% to $77 million, highlighting weaknesses in market competitiveness.
- Strategic Shift: The company acknowledged that its strategy of “adjacencies, collaborations, and promotions” failed to effectively grow its customer base, deciding to exit certain adjacencies and refocus on core categories to improve performance and restore growth.
- Legal Action: The class action lawsuit alleges that the company failed to disclose significant adverse facts about its business and prospects during the class period, misleading investors and potentially exposing them to greater legal and financial risks.
See More
Class Action Lawsuit Filed Against Bath & Body Works, Inc.
- Lawsuit Background: Bath & Body Works, Inc. (NYSE: BBWI) is facing a class action lawsuit for alleged violations of federal securities laws, targeting the company and its officers on behalf of investors who purchased securities between June 4, 2024, and November 19, 2025.
- Allegations Details: The complaint alleges that throughout the class period, defendants made materially false and misleading statements while failing to disclose adverse facts about the company's business and prospects, misleading investors regarding its financial health.
- Financial Guidance Missteps: The lawsuit claims that the company's strategy of pursuing
See More
Class Action Notice for Bath & Body Works Securities
- Class Action Notice: Rosen Law Firm reminds investors who purchased Bath & Body Works securities between June 4, 2024, and November 19, 2025, that they must apply to be lead plaintiff by March 16, 2026, to participate in the class action and potentially receive compensation.
- Lawsuit Background: The lawsuit alleges that Bath & Body Works made materially false statements during the Class Period, failing to disclose that its strategy of 'adjacencies, collaborations, and promotions' was not effectively growing its customer base, resulting in investor losses.
- Law Firm Advantages: Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, demonstrating its successful track record and resource advantages, urging investors to select experienced legal counsel wisely.
- Investor Action Recommendations: Investors can visit Rosen Law Firm's website or call the toll-free number for more information on how to participate in the lawsuit, ensuring they have appropriate legal representation in the class action.
See More
Multiple Companies Face Class Action Lawsuits
- Varonis Systems Lawsuit: During the class period from February 4, 2025, to October 28, 2025, Varonis is accused of failing to sustain its annual recurring revenue growth, which has severely undermined investor confidence in the company's prospects, with a lead plaintiff deadline set for March 9, 2026.
- Ardent Health Allegations: Ardent Health faces accusations from July 18, 2024, to November 12, 2025, of inaccurately assessing the collectability of accounts receivable, leading to significant misrepresentation of its financial health, with investors required to act by March 9, 2026.
- CoreWeave Risk Disclosure: CoreWeave is alleged to have overstated its ability to meet customer demand during the period from March 28, 2025, to December 15, 2025, failing to adequately disclose the risks associated with reliance on a single third-party data center, which could materially impact revenue, with a lead plaintiff deadline of March 13, 2026.
- Bath & Body Works Financial Misrepresentation: Bath & Body Works is accused of failing to meet its financial guidance during the period from June 4, 2024, to November 19, 2025, with its brand collaboration strategy not effectively growing its customer base, requiring investor action by March 16, 2026.
See More
